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Introduction
• Lung Transplants are a unique challenge as 
these organs require prevention from rejection 
but must still be able to defend against exposure 
to outside pathogens
• Patients are treated with Immunosuppressive 
Drugs (ISDs) to prevent transplant rejection
• ISDs prevent rejection AND inhibit immune 
response to pathogenic microbes (1).
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Methods
• Human Monocyte Cell Lineage (THP-1s) were treated with Immunosuppressive regimen used in Lung Transplants 
which included Cyclosporin A, Azathioprine, and Prednisone.
• Cells were harvested at different time points (15min, 2 hours, 4 hours) to check for the percent of cells with 
completed antigen presentation through Flow Cytometry.
• THP-1s were treated with PMA to allow for differentiation into macrophages. 
• Differentiated THP-1s were then treated with course of ISDs followed by transfection or treatment with different viral 
mimics as well as LPS and CpGA (bacterial mimics).
• Cells were harvested the following day and RNA from cells was extracted.
• RNA from cells was then synthesized into cDNA to allow for running on the PCR.





How do ISDs affect Innate 
Immune Response to Pathogens?
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• Immunosuppressants prevent 
rejection by acting against the 
adaptive immune system response to 
the graft (2).
• Immunosuppressants suppress the 
presentation function of dendritic cells
• Exposure to pathogens in the lung 
occurs in the alveolar space
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Figure 1: ISD effect on Monocyte Differentiation into 
Macrophages
• The presence of ISDs 
acidified and cleaved a 
higher percent of cells 
compared to the non-
ISD control cells
• Presence of ISDs seems 
to allow processing of 
antigen (% cleaved 
cells) but prevents full 
degradation of FITC 
marker (seen in the 
normal non-ISD treated 
cells at different time 
points)
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Figure 3: M1 associated Gene Expression
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Figure 4: M2 Associated Gene Expression
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1. Assess dendritic cells in response to ISDs:
• Gene expression
• Differentiation capabilities
• Functional innate response to viral mimics
• Chemotaxis 
2. Conduct experiments that test the mechanism of action of Immunosuppressive Drugs that prevent Monocyte differentiation into 
Macrophages
3. Assess what property of specific ISDs allows some viral and bacterial mimics to prevent an immune response vs. illicit an immune 
response even in the presence of Immunosuppressive Drugs.
4. Reconduct ISD response to Viral Mimic exposed Macrophages experiment
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Innate Immunity Related Gene Expression in Macrophages treated with Immunosuppressive 
Drugs in the presence of Viral Mimics (and some bacterial). 
M2 (Wound Healing) Related Gene Expression in Macrophages treated with 
Immunosuppressive Drugs in the presence of Viral Mimics (and some bacterial). 
M1 (Pro-inflammatory) Related Gene Expression in Macrophages treated with 
Immunosuppressive Drugs in the presence of Viral Mimics (and some bacterial). 
